Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
48,932,355
-
Total 13F shares
-
23,961,301
-
Share change
-
-106,335
-
Total reported value
-
$1,950,823,589
-
Put/Call ratio
-
128%
-
Price per share
-
$81.47
-
Number of holders
-
175
-
Value change
-
-$4,075,043
-
Number of buys
-
82
-
Number of sells
-
69
Institutional Holders of Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) as of Q4 2020
As of 31 Dec 2020,
Axsome Therapeutics, Inc. - Common Stock, $0.0001 par value per share (AXSM) was held by
175 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
23,961,301 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., IRIDIAN ASSET MANAGEMENT LLC/CT, RTW INVESTMENTS, LP, RA CAPITAL MANAGEMENT, L.P., PRICE T ROWE ASSOCIATES INC /MD/, ALETHEA CAPITAL MANAGEMENT, LLC, PICTET ASSET MANAGEMENT LTD, BAKER BROS. ADVISORS LP, and CITADEL ADVISORS LLC.
This page lists
176
institutional shareholders reporting positions in this security
for the Q4 2020 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.